inavolisib
Showing 1 - 15 of 15
Metastatic Breast Cancer Trial (Inavolisib, Phesgo, Placebo)
Not yet recruiting
- Metastatic Breast Cancer
- Inavolisib
- +4 more
- (no location specified)
Jun 7, 2023
Breast Cancer Trial (Inavolisib, Fulvestrant, Alpelisib)
Not yet recruiting
- Breast Cancer
- Inavolisib
- +2 more
- (no location specified)
Jan 30, 2023
HER2-positive Breast Cancer Trial (Inavolisib, PHESGO, Endocrine therapy)
Not yet recruiting
- HER2-positive Breast Cancer
- Inavolisib
- +2 more
- (no location specified)
Mar 23, 2022
Breast Cancer, Solid Tumor Trial in Worldwide (Inavolisib, Fulvestrant, Letrozole)
Recruiting
- Breast Cancer
- Solid Tumor
- Inavolisib
- +6 more
-
Boston, Massachusetts
- +12 more
Jan 10, 2023
Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)
Not yet recruiting
- Early-stage Breast Cancer
- Atezolizumab 1200 mg in 20 ML Injection
- +5 more
-
Heidelberg, Baden-Wuerttemberg, GermanyNational Center for Tumor Diseases
Sep 13, 2022
Metastatic or Locally Advanced Malignancies Trial in Germany (Vemurafenib, Cobimetinib, Atezolizumab)
Recruiting
- Metastatic or Locally Advanced Malignancies
- Vemurafenib
- +7 more
-
Berlin, Germany
- +5 more
Jan 2, 2023
Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)
Recruiting
- Breast Cancer
- Triple Negative Breast Cancer
- Capecitabine
- +4 more
-
Washington, District of Columbia
- +5 more
Jan 12, 2023
Breast Cancer Trial in Worldwide (Inavolisib, Placebo, Palbociclib)
Recruiting
- Breast Cancer
- Inavolisib
- +3 more
-
Tucson, Arizona
- +228 more
Jan 10, 2023
Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer Trial in Worldwide (Giredestrant, Abemaciclib,
Recruiting
- Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
- Giredestrant
- +9 more
-
Duarte, California
- +27 more
Jan 31, 2023
Metastatic Colorectal Cancer Trial in Worldwide (Inavolisib, Bevacizumab, Cetuximab)
Recruiting
- Metastatic Colorectal Cancer
- Inavolisib
- +7 more
-
Birmingham, Alabama
- +36 more
Dec 29, 2022
NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)
Recruiting
- Non-Small Cell Lung Cancer
- +2 more
- GDC-6036
- +6 more
-
Duarte, California
- +68 more
Jan 10, 2023
Advanced Unresectable or Metastatic Solid Malignancy Trial in United States (Entrectinib, Inavolisib, Alectinib)
Recruiting
- Advanced Unresectable or Metastatic Solid Malignancy
- Entrectinib
- +11 more
-
Birmingham, Alabama
- +50 more
Aug 10, 2022